Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.86 |
| ▸ | RAB9A | P51151 | 4/20 | 0.86 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.86 |
| ▸ | TSHR | P16473 | 3/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.86 |
| ▸ | TP53 | P04637 | 1/20 | 0.86 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.86 |
| ▸ | PTPRC | P08575 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | APAF1 | O14727 | 1/20 | 0.74 |
| ▸ | TDP2 | O95551 | 1/20 | 0.74 |
| ▸ | NSD2 | O96028 | 1/20 | 0.74 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | CTSL | P07711 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28005394 | 0.97 | NPC1 (0.82) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL9019017 | 0.95 | NPC1 (0.78) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL31087632 | 0.95 | NPC1 (0.78) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL30350052 | 0.94 | NPC1 (0.77) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL9019051 | 0.94 | NPC1 (0.77) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL864582 | 0.94 | NPC1 (0.77) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| Anthraquinone SCHEMBL23363689 | 0.93 | NPC1 (1.00) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL31290097 | 0.93 | NPC1 (1.00) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL40960 | 0.93 | NPC1 (1.00) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL6938108 | 0.92 | NPC1 (0.74) | NPC1ALDH1A1RAB9ASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250118786-A1 | LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL | HARVARD COLLEGE (US) | 2025-04-10 | — | — | US | claimed |
| CN-119613919-A | MXene composite material and preparation method and application thereof | 中山大学 | 2025-03-14 | — | — | CN | claimed |
| CN-118852700-B | Preparation method of high-color-fastness flame-retardant PA66 film and PA66 fiber | 江苏新视界先进功能纤维创新中心有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118852700-A | Preparation method of high-color-fastness flame-retardant PA66 film and PA66 fiber | 江苏新视界先进功能纤维创新中心有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118440318-A | Anthraquinone-imino polymer and its synthesis and application | 武汉大学 | 2024-08-06 | — | — | CN | claimed |
| EP-4387954-A1 | LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL | President and Fellows of Harvard College (US) | 2024-06-26 | — | — | EP | claimed |
| WO-2023023303-A1 | LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-02-23 | — | — | WO | claimed |
| US-20090253709-A1 | SYNTHESIS, TELOMERASE INHIBITION AND CYTOTOXIC STUDIES ON 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2009-10-08 | — | — | US | claimed |
| US-7291223-B2 | Epitaxial organic layered structure and method for making | NITTO DENKO CORPORATION (JP) | 2007-11-06 | — | — | US | claimed |
| JP-2007504305-A | — | — | 2007-03-01 | — | — | JP | claimed |
| US-7166161-B2 | Anisotropic film manufacturing | NITTO DENKO CORPORATION (JP) | 2007-01-23 | — | — | US | claimed |
| US-20050103258-A1 | Epitaxial organic layered structure and method for making | INSOLVENCY SERVICES GROUP, INC. | 2005-05-19 | — | — | US | claimed |
| WO-2005032217-A1 | EPITAXIAL ORGANIC LAYERED STRUCTURE AND METHOD FOR MAKING | NITTO DENKO CORPORATION (JP) | 2005-04-07 | — | — | WO | claimed |
| US-20040224182-A1 | Backlight polar organic light-emitting device | INSOLVENCY SERVICES GROUP, INC. | 2004-11-11 | — | — | US | claimed |
| WO-2004064112-A2 | BACKLIGHT POLAR ORGANIC LIGHT-EMITTING DEVICE | NITTO DENKO CORPORATION (JP) | 2004-07-29 | — | — | WO | claimed |
| US-20040142183-A1 | Anisotropic film manufacturing | INSOLVENCY SERVICES GROUP, INC. | 2004-07-22 | — | — | US | claimed |
| EP-0577245-B1 | Photogenerating azo pigments | XEROX CORP (US) | 1998-12-02 | — | — | EP | claimed |
| US-5281503-A | Multilayer element with disazo pigments and charge generating layer | XEROX CORPORATION (US) | 1994-01-25 | — | — | US | claimed |
| EP-0577245-A1 | Photogenerating azo pigments | XEROX CORPORATION (US) | 1994-01-05 | — | — | EP | claimed |
| EP-0406952-A2 | Aromatic polymer with diaminoanthraquinone units | STAMICARBON B.V. (NL) | 1991-01-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250118786-A1 | LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL | GPX4, GPX1, NOX4 | NPC1 4346/4885ALDH1A1 326/4885RAB9A 1377/4885 |
| US-20090253709-A1 | SYNTHESIS, TELOMERASE INHIBITION AND CYTOTOXIC STUDIES ON 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES | TERT, NAT10, POT1 | NPC1 2511/4885ALDH1A1 481/4885RAB9A 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.